Life Technologies | Resultat Før Skat



Pre Tax Profit Lave om Dato
Ardelyx USD 4.68M 5.45M 2024-12
Biogen USD 572.2M 118.5M 2024-12
Bristol-Myers Squibb USD 4.26B 226M 2024-12
Cipla INR 19.16B 1.27B 2024-12
Clal Biotechnology ILS 86.82M 17.9M 2022-12
Compugen USD 5.78M 7.89M 2024-09
CSL USD 1.2B 1.36B 2024-06
Galapagos EUR 19.03M 68.17M 2024-12
GlaxoSmithKline GBP 563M 2.08B 2024-12
Grifols 66.98M 19.92M 2024-06
Life Technologies USD -17261000 955K 2024-09
Novartis USD 4.66B 269M 2024-12
Roche Holding CHF 1.78B 2.33B 2024-12
United Therapeutics USD 396.5M 7.9M 2024-12



Life Technologies Resultat Før Skat - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2025.